Found: 6
Select item for more details and to access through your institution.
Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 10, p. 1, doi. 10.1093/ofid/ofad482
- By:
- Publication type:
- Article
SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis.
- Published in:
- European Respiratory Review, 2023, v. 32, n. 169, p. 1, doi. 10.1183/16000617.0254-2022
- By:
- Publication type:
- Article
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 12, p. 1626, doi. 10.1093/cid/ciad460
- By:
- Publication type:
- Article
INCIDENCE OF LONG COVID SYMPTOMS IN PATIENTS PREVIOUSLY HOSPITALIZED FOR COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 285
- By:
- Publication type:
- Article
REMDESIVIR REDUCES MORTALITY IN IMMUNOCOMPROMISED PATIENTS HOSPITALIZED FOR COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 219
- By:
- Publication type:
- Article
Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02550-0
- By:
- Publication type:
- Article